Lysa Buonanno, Dr. David Carbone

In this ROS1 Biomarker video you will learn the answers to these questions:

  1. What is the best way to determine the next best treatment for #ros1 #biomarker lung cancer after progression?
  2. Should you get another biopsy after progression with ROS1 Biomarker lung cancer?

ROS1 Biomarker Lung Cancer

Patients with #ROS1 #Biomarker #lungcancer tumors are often treated with a type of targeted therapy called a Tyrosine Kinase Inhibitor, or TKI.

In this video, Lysa Buonanno, who is a lung cancer patient and advocate, goes a little deeper with questions about ROS1 biomarker lung cancer. Dr. David Carbone, of The James Cancer Center at Ohio State University, provides the answers.

Dr. Carbone outlines the possible treatment plans for a patient with a ROS1 Biomarker tumor if their disease progresses while they are taking a TKI. Dr. Carbone suggests several different options, including:

  • Continuing on the TKI but adding stereotactic radiation to shrink a small number of spots that are growing
  • Taking another biopsy to look at the features of the tumor that made it resistant to the TKI

Overall, ROS1 lung cancer prognosis is improving through discoveries in lung cancer research. There are more treatment options now than ever, and a lot of reasons for hope for patients with ROS1 biomarker lung cancer.

ROS1 Biomarker Hope With Answers℠ Videos

Available online, anytime you need it and anywhere you are, Hope With Answers℠ videos pair lung cancer patients with leading lung cancer doctors. The patients ask the questions that matter most to lung cancer patients. And, they get the answers from doctors who specialize in lung cancer. These lung cancer specialists dedicate their careers to staying up to date on the best tests, the latest effective treatment options, and what exciting things are on the horizon to help lung cancer patients. The Hope With Answers℠ video series includes videos on biomarker testing, staging in lung cancer, targeted therapies, immunotherapies, thoracic surgery, ROS1 biomarker, ALK biomarker, clinical trials, and much more. The videos are designed as stepping stones. The Intro videos discuss the most basic information. The intermediate videos offer more profound knowledge. And, the in-depth videos provide the most intricate details.